(Press-News.org) In recent years, doctors and scientists are increasingly studying long-lasting illnesses that begin after someone recovers from an infection. Two of the most well-known examples are long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
It has been estimated that 400 million people, globally, may have Long COVID, and nearly half of them meet criteria for ME/CFS.
These conditions were often misunderstood or overlooked in the past, but that is starting to change. Researchers are now studying them as part of a larger group of illnesses called post-acute infection syndromes, or PAISs.
A new review by Mass General Brigham investigator Anthony L Komaroff, MD, and Robert Dantzer, MD, of the MD Anderson Cancer Center in Houston, published in Cell Reports Medicine, and a new review by Dr. Komaroff in the Proceedings of the National Academy of Sciences (PNAS), brings together decades of research and new discoveries to help explain what causes these illnesses and how they might be treated. Dr. Dantzer is one of the world’s experts on how animals respond to infection.
Their review highlights that long COVID and ME/CFS share many of the same biological problems such as inflammation in the brain, issues with how cells produce energy, and problems with the immune system.
They also introduce the idea that certain brain circuits that evolved to help the body respond to serious illness, may be stuck in the "on" position after the body has cleared the infection and could be causing many of the ongoing symptoms people experience.
In this Q&A, Dr. Komaroff shares what motivated this research and what it could mean for how we understand, diagnose, and treat these complex conditions.
Q: What Inspired You to Study the Field of Long Covid and other Post-Acute Infection Syndromes?
My interest in ME/CFS began more than 40 years ago, when I met patients who never fully recovered from what seemed like a routine viral illness.
At the time, their symptoms couldn’t be explained by standard medical tests, which all came back normal. That led some to conclude the symptoms were psychologically based.
A small group of us around the world began to study if there were, in fact, underlying objective biological abnormalities that might be causing the long-lasting symptoms, perhaps in people with a genetic vulnerability.
Over the past 40 years, it became clear that this is the case. The symptoms are associated with multiple underlying abnormalities, involving multiple body systems.
In both reviews, we postulate that Long COVID and ME/CFS fall under a broader category called post-acute infection syndromes.
This helps highlight the biological similarities between them and opens the door to more targeted treatments.
Q: What Did You Find in this Review?
In the review we asked two questions: what causes the symptoms, and why do the symptoms persist for years?
What causes the symptoms?
We identified a range of biological abnormalities common to both ME/CFS and long COVID that can directly cause symptoms.
These include:
Neuroinflammation: Activation of the brain’s immune system
Mitochondrial dysfunction: A reduced capacity to generate adenosine triphosphate (ATP), the primary energy source for cells, leading to a decrease in body- and brain-based metabolism.
Immune dysregulation: This can include persistent inflammation, reactivation of latent viruses (like Epstein-Barr virus), and the presence of autoantibodies targeting neural tissues.
Endothelial dysfunction: Disruption of blood flow and the blood-brain barrier, contributing to cognitive and cardiovascular symptoms.
Gut dysbiosis: An imbalance in the gut microbiome that may perpetuate system inflammation
Oxidative stress: An imbalance between the production of free radicals and the body's ability to neutralize them, leading to cellular damage and disease
Could "sickness behavior" be underlying these symptoms?
Our review focuses on another possible cause of the symptoms that has not previously been considered.
We think it is likely that these symptoms may be driven by evolutionarily-conserved responses to vital threats that are seen in all animals that have been studied.
Infection leads to symptoms, and the symptoms lead to behavior changes called sickness behavior. Infection also leads to changes in metabolism. Together, the behavioral and metabolic changes help preserve the body’s energy supply, its ATP, for the fight against the infection.
We suspect these behavioral and metabolic changes may be caused by recently discovered groups of dedicated brain cells (neurons) when they are stimulated by an infection or other cause of brain inflammation.
We present evidence that many of the underlying abnormalities that produce symptoms persist in some people, including the infectious agent or pieces of the infectious agent.
In addition, we point out that many of the different underlying abnormalities can reinforce each other, leading to ongoing vicious cycles that maintain the symptoms.
Q: How has the COVID-19 pandemic and Long COVID changed the scientific and public perception of ME/CFS?
The pandemic has been a turning point. In 2020, we published a paper predicting that COVID-19 would lead to a surge in ME/CFS-like conditions, and that has happened.
Long COVID has brought visibility to post-infectious syndromes, because its cause is a specific infectious agent.
This has given credibility to the claim of many ME/CFS patients that their illness began following an acute infection—one in which no infectious agent was tested for.
It also gives credibility to similar syndromes following well-documented acute infections like Lyme disease and West Nile virus.
The scale of long COVID’s impact—both in terms of affected individuals and societal costs—has accelerated research and shifted the public discourse.
Q: What are the most interesting biological similarities between ME/CFS and long COVID?
The symptom overlap between ME/CFS and long COVID is well recognized. What our publications have cataloged is the many striking parallels in the underlying abnormalities.
These biological parallels include:
Brain abnormalities, as seen by various types of brain imaging.
Autonomic nervous system dysfunction affecting heart rate, breathing, and digestion.
Immune system dysregulation and autoantibodies
Impaired energy metabolism leading to fatigue and exercise intolerance.
Cardiovascular issues, especially involving the lining of blood vessels (the endothelium).
These similarities suggest a shared pathophysiological foundation, reinforcing the case for unified research and treatment strategies.
Q: What are the current treatments for post-acute infection syndrome, and why have some failed to be effective?
Currently, there are no FDA-approved treatments for ME/CFS or long COVID. However, evidence shows that early antiviral treatment and vaccination against SARS-CoV-2 can reduce the risk of developing long COVID.
Our review proposes that neuroinflammation—immune activation within the brain—is one key driver of symptoms. It stimulates the specific neural circuits that produce sickness behavior and metabolic changes.
Therefore, targeting neuroinflammation and the molecules by which it stimulates the neural circuits could lead to more effective therapies. Multiple novel therapies that target neuroinflammation are under investigation.
While promising, these treatments are still in experimental stages and not yet available to clinicians
Q: What are the most important research questions that need to be addressed to better understand and treat ME/CFS and long COVID?
Two major questions stand out:
Cross-condition biological parallels: Do other post-infection syndromes—like post-Lyme disease, post-Ebola, and post-West Nile virus—share the same biological abnormalities as ME/CFS and long COVID? Systematic studies are needed to confirm this.
Therapeutic targeting of neuroinflammation: There are 10–20 experimental approaches currently being tested in lab models to reduce neuroinflammation. Determining which, if any, are effective in humans is a critical next step.
These questions are central to advancing treatment and understanding the broader category of post-acute infection syndromes
Finally, it's important to raise awareness.
The idea of post-acute infection syndromes is still relatively new and not yet widely recognized in medical practice. Promoting this framework can help improve how we diagnose, study, and treat these long-lasting illnesses.
END
Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes
2025-08-01
ELSE PRESS RELEASES FROM THIS DATE:
Study reveals hidden drivers of asthma flare-ups in children
2025-08-01
A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics.
Eosinophilic asthma is characterized by high levels of eosinophils, a type of white blood cell involved in the body’s immune response. While eosinophils typically help fight infections, in eosinophilic asthma, they accumulate in the lungs and airways, causing chronic inflammation, swelling and damage to the respiratory system.
Eosinophilic asthma is driven by type 2 (T2) inflammation, an immune response ...
Physicists decode mysterious membrane behavior
2025-08-01
Cell membranes cradle, protect, and gatekeep living cells. Membranes can even affect how a cell behaves.
But membranes’ own erratic behavior has puzzled scientists for years.
Turns out, it’s all about perspective: When physicist Rana Ashkar’s team members looked at how membranes behave on the nanoscale, they were able to identify unified biophysical laws that membranes have adhered to all along.
Published in Nature Communications, these findings have significant implications for disease ...
New insights about brain receptor may pave way for next-gen mental health drugs
2025-08-01
New York, NY [August 1, 2025]— In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers at the Icahn School of Medicine at Mount Sinai have developed new insights into how a critical brain receptor works at the molecular level and why that matters for mental health treatments.
The study, published in the August 1 online issue of Science Advances, focuses on the 5-HT1A serotonin receptor, a major player in regulating mood and a common target of both traditional antidepressants and newer therapies such as psychedelics. Despite its ...
Melanoma ‘sat-nav’ discovery could help curb metastasis
2025-08-01
Researchers have discovered a protein which is critical for steering melanoma cancer cells as they spread throughout the body. The malignant cells become dependent on this protein to migrate, pointing to new strategies for impeding metastasis.
The protein eIF2A is generally thought to spring into action when a cell is under stress, helping ribosomes launch protein synthesis. But according to a study published today in the journal Science Advances, eIF2A has a completely different role in melanoma, helping cancerous cells control movement.
“Malignant cells that metastasize ...
When immune commanders misfire: new insights into rheumatoid arthritis inflammation
2025-08-01
Researchers at Kyoto University have discovered that an immune molecule found only in primates, called IGFL2, plays a key role in regulating inflammation in rheumatoid arthritis (RA). IGFL2 is produced by a subset of immune cells in the joints of patients with RA and acts like fuel on a fire: it activates more immune cells, further amplifying inflammation and worsening joint damage. They also found that IGFL2 levels were much higher in the blood of patients with RA, especially in those with more severe symptoms. These findings support IGFL2’s potential as a diagnostic marker, a tool for monitoring disease progression, ...
SFU researchers develop a new tool that brings blender-like lighting control to any photograph
2025-08-01
Lighting plays a crucial role when it comes to visual storytelling. Whether it’s film or photography, creators spend countless hours, and often significant budgets, crafting the perfect illumination for their shot. But once a photograph or video is captured, the illumination is essentially fixed. Adjusting it afterward, a task called “relighting,” typically demands time-consuming manual work by skilled artists.
While some generative AI tools attempt to tackle this task, they rely on large-scale neural networks and billions of training images to guess how light might interact with a scene. But the process is often ...
Pups in tow, Yellowstone-area wolves trek long distances to stay near prey
2025-08-01
Berkeley — Gray wolf pups are born nearly helpless: blind, deaf and lacking the acute sense of smell of their elders. They usually remain in the safe confines of their den until they are at least three weeks old.
That is why UC Berkeley biologists were surprised to observe gray wolves near Yellowstone National Park traveling 20 kilometers or more over rugged, mountainous terrain, with very young pups in tow.
“The first time I saw a camera trap photo of a wolf carrying its pup, I just cracked up because the pup is being carried by its butt,” said Avery Shawler, first author of a new study presenting the findings, which appeared ...
AI breakthrough unlocks 'new' materials to replace lithium-ion batteries
2025-08-01
Researchers from New Jersey Institute of Technology (NJIT) have used artificial intelligence to tackle a critical problem facing the future of energy storage: finding affordable, sustainable alternatives to lithium-ion batteries.
In research published in Cell Reports Physical Science, the NJIT team led by Professor Dibakar Datta successfully applied generative AI techniques to rapidly discover new porous materials capable of revolutionizing multivalent-ion batteries. These batteries, using abundant elements like magnesium, calcium, aluminum and zinc, offer a promising, cost-effective alternative to lithium-ion batteries, ...
Making molecules make sense: A regional explanation method reveals structure–property relationships
2025-08-01
In cheminformatics, where machine learning is transforming our understanding of how molecular properties are predicted and explained, a critical challenge has long remained: making these powerful but often "black box" models easier to interpret. Recently, researchers at the Australian National University developed a breakthrough solution: a "regional explanation" method that helps reveal how molecular structures drive their properties. This research was published June 3 in Intelligent ...
Partisan hostility, not just policy, drives U.S. protests
2025-08-01
Partisan animosity is a powerful driver of protest participation -- sometimes nearly matching or even exceeding concern about the actual issues, according to a new study published in the journal Social Forces.
The research, conducted by political scientist Seth Warner at the University of Connecticut, analyzed three nationally representative surveys fielded between 2014 and 2022. Each focused on a different protest movement: Black Lives Matter, the climate movement, and the Tea Party.
Warner matched survey questions to these movements’ core grievances ...